Search

Asuragen has researched and published extensively in genetics, oncology, molecular diagnostics, and technology advancements for over 15 years. These publications, posters, and white papers cover various disease areas and their related genes including fragile X (FMR1), spinal muscular atrophy (SMN1/SMN2), cystic fibrosis (CFTR), and chronic myeloid leukemia (BCR-ABL1). They show the power of detecting and interpreting molecular alterations using AmplideX and QuantideX technologies as well as the value of Molecular Quality Controls and companion diagnostics collaborations to deliver new insights and advance precision medicine. Simply search by term, filter by category, or use both to find your area of interest.

We’re driven to provide people with better answers, so we ensure our products are supported by reliable data and backed by rigorous science. Dive into these publications to learn more.

Beta evaluation of AmplideX® PCR enrichement technology with Nanopore long-read DNA sequencing of a panel of eleven challenging genes
Lebre A.S.
Equivalent Performance of the Applied Biosystems™ 3500 and SeqStudio™ Flex Genetic Analyzer CE Systems for AmplideX® Gene Variant Analysis
Combining AmplideX® PCR Chemistries, Nanopore Sequencing, and Automated Analysis Software to Genotype Complex, Clinically-relevant Variants in 11 Challenging Targets Associated with Hereditary Diseases
John N. Milligan, Bryan J. Killinger, Cody Edwards, Christopher J. Fraher, Jon Kemppainen, Monica Roberts, Jonathan Turner, Theodore Markulin, Brennan Greenlee, Eduardo Priego, Juliette A. Baker, Mahesh Yarasi, Connor Parker, Mia K. Mihailovic, Ashima Sharma, Brian C. Haynes, and Bradley Hall
Beta evaluation of AmplideX® PCR enrichement technology with Nanopore long-read DNA sequencing of a panel of eleven challenging genes
Feyereisen L, Yammine T, Landais E, Moret H, Audrézet M-P, Bonello-Palot N, Rouzier C, Pissard S, Gueguen P, Metay C, Froissart R, Bekri S, Bellanné-Chantelot C, Lebre AS
Accessible AmplideX® PCR and Nanopore Sequencing For Rare Variant Characterization in 11 Challenging Genes Associated with Hereditary Diseases
Bradley Hall, Anne-Sophie Lebre, Tony Yammine, Cody Edwards, Theodore Markulin, Bryan Killinger, Jacob Ashton, Christopher J. Fraher, and Brian C. Haynes
Performance and Compatibility of the Promega Spectrum Compact CE System for Performing AmplideX® Gene Variant Analysis
Dried Blood Spot Testing with AmplideX® SMA Plus* Resolves SMN1 and SMN2 Exon 7 Copies
Dried Blood Spot Testing with AmplideX® SMA Plus* Kit Resolves SMN1 and SMN2 Exon 7 Copy Numbers and More
Sarah Edelmon, Walairat Laosinchai-Wolf, Laura Blasco-Pérez, Mar Costa-Roger, Ivon Cuscó, Gary J Latham, Eduardo F Tizzano, and John N Milligan
Buccal Swab Testing with the AmplideX® PCR/CE SMN1/2 Plus Kit that Assesses Copy Number and Critical Mutations for SMA (eP418)
Justin Janovsky- Presented at ACMG 2021
AmplideX PCR/CE CFTR Prototype Assay has Broad Coverage for Diverse Populations
Shoba Gokul - Presented at ESHG
Search
Filter

Publication Categories

Publication Types

Clear All Filters
Back To
Top